vs

Side-by-side financial comparison of Simulations Plus, Inc. (SLP) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

Simulations Plus, Inc. is the larger business by last-quarter revenue ($18.4M vs $14.5M, roughly 1.3× SS Innovations International, Inc.). Simulations Plus, Inc. runs the higher net margin — 3.7% vs -17.0%, a 20.7% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs -2.7%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 0.3%).

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

SLP vs SSII — Head-to-Head

Bigger by revenue
SLP
SLP
1.3× larger
SLP
$18.4M
$14.5M
SSII
Growing faster (revenue YoY)
SSII
SSII
+81.7% gap
SSII
79.1%
-2.7%
SLP
Higher net margin
SLP
SLP
20.7% more per $
SLP
3.7%
-17.0%
SSII
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
0.3%
SLP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
SLP
SLP
SSII
SSII
Revenue
$18.4M
$14.5M
Net Profit
$676.0K
$-2.5M
Gross Margin
59.1%
43.9%
Operating Margin
3.9%
-3.7%
Net Margin
3.7%
-17.0%
Revenue YoY
-2.7%
79.1%
Net Profit YoY
228.2%
-28.5%
EPS (diluted)
$0.03
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLP
SLP
SSII
SSII
Q4 25
$18.4M
$14.5M
Q3 25
$17.5M
$12.8M
Q2 25
$20.4M
$10.0M
Q1 25
$22.4M
$5.1M
Q4 24
$18.9M
$8.1M
Q3 24
$18.7M
$4.4M
Q2 24
$18.5M
$4.5M
Q1 24
$18.3M
$3.6M
Net Profit
SLP
SLP
SSII
SSII
Q4 25
$676.0K
$-2.5M
Q3 25
$-681.0K
$-3.7M
Q2 25
$-67.3M
$-256.7K
Q1 25
$3.1M
$-5.7M
Q4 24
$206.0K
$-1.9M
Q3 24
$843.0K
$-3.2M
Q2 24
$3.1M
$-4.1M
Q1 24
$4.0M
$-9.8M
Gross Margin
SLP
SLP
SSII
SSII
Q4 25
59.1%
43.9%
Q3 25
56.4%
48.1%
Q2 25
64.0%
59.1%
Q1 25
58.5%
21.2%
Q4 24
54.0%
48.9%
Q3 24
36.6%
52.8%
Q2 24
71.5%
31.9%
Q1 24
72.2%
20.0%
Operating Margin
SLP
SLP
SSII
SSII
Q4 25
3.9%
-3.7%
Q3 25
3.8%
-14.3%
Q2 25
-364.5%
1.0%
Q1 25
12.1%
-115.6%
Q4 24
0.7%
-22.7%
Q3 24
-6.2%
-73.1%
Q2 24
10.1%
-90.9%
Q1 24
24.3%
-270.3%
Net Margin
SLP
SLP
SSII
SSII
Q4 25
3.7%
-17.0%
Q3 25
-3.9%
-29.0%
Q2 25
-330.6%
-2.6%
Q1 25
13.7%
-111.0%
Q4 24
1.1%
-23.7%
Q3 24
4.5%
-74.0%
Q2 24
16.9%
-91.8%
Q1 24
22.0%
-270.5%
EPS (diluted)
SLP
SLP
SSII
SSII
Q4 25
$0.03
$-0.01
Q3 25
$-0.03
$-0.02
Q2 25
$-3.35
$0.00
Q1 25
$0.15
$-0.03
Q4 24
$0.01
$-0.01
Q3 24
$0.04
$-0.02
Q2 24
$0.15
$-0.02
Q1 24
$0.20
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLP
SLP
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$35.7M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$127.1M
$38.2M
Total Assets
$137.8M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLP
SLP
SSII
SSII
Q4 25
$35.7M
$3.2M
Q3 25
$32.4M
$5.7M
Q2 25
$28.4M
$11.4M
Q1 25
$21.4M
$15.9M
Q4 24
$18.2M
$466.5K
Q3 24
$20.3M
$220.4K
Q2 24
$119.0M
$608.2K
Q1 24
$108.5M
$948.1K
Stockholders' Equity
SLP
SLP
SSII
SSII
Q4 25
$127.1M
$38.2M
Q3 25
$124.8M
$39.6M
Q2 25
$123.8M
$42.0M
Q1 25
$189.5M
$40.6M
Q4 24
$184.7M
$13.5M
Q3 24
$182.4M
$13.7M
Q2 24
$180.9M
$14.8M
Q1 24
$177.0M
$16.7M
Total Assets
SLP
SLP
SSII
SSII
Q4 25
$137.8M
$74.2M
Q3 25
$131.9M
$69.6M
Q2 25
$134.4M
$70.0M
Q1 25
$201.4M
$63.5M
Q4 24
$196.9M
$42.4M
Q3 24
$196.6M
$39.0M
Q2 24
$192.7M
$35.7M
Q1 24
$194.0M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLP
SLP
SSII
SSII
Operating Cash FlowLast quarter
$4.2M
$-1.5M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
0.0%
11.8%
Cash ConversionOCF / Net Profit
6.26×
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLP
SLP
SSII
SSII
Q4 25
$4.2M
$-1.5M
Q3 25
$5.6M
$-7.5M
Q2 25
$8.1M
$-3.5M
Q1 25
$5.7M
$-6.1M
Q4 24
$-1.3M
$-3.3M
Q3 24
$1.7M
$-2.5M
Q2 24
$5.7M
$-1.0M
Q1 24
$5.8M
$-2.7M
Free Cash Flow
SLP
SLP
SSII
SSII
Q4 25
$-3.2M
Q3 25
$5.3M
$-8.2M
Q2 25
$7.8M
$-3.8M
Q1 25
$5.6M
$-7.0M
Q4 24
$-1.4M
$-3.4M
Q3 24
$1.6M
$-4.2M
Q2 24
$5.6M
$-3.1M
Q1 24
$5.4M
$-2.8M
FCF Margin
SLP
SLP
SSII
SSII
Q4 25
-22.3%
Q3 25
30.5%
-64.1%
Q2 25
38.5%
-37.7%
Q1 25
25.0%
-136.2%
Q4 24
-7.2%
-41.7%
Q3 24
8.8%
-96.9%
Q2 24
30.0%
-69.5%
Q1 24
29.4%
-76.9%
Capex Intensity
SLP
SLP
SSII
SSII
Q4 25
0.0%
11.8%
Q3 25
1.5%
5.9%
Q2 25
1.5%
3.2%
Q1 25
0.3%
17.0%
Q4 24
0.5%
1.5%
Q3 24
0.1%
38.8%
Q2 24
0.6%
46.8%
Q1 24
2.4%
3.5%
Cash Conversion
SLP
SLP
SSII
SSII
Q4 25
6.26×
Q3 25
Q2 25
Q1 25
1.84×
Q4 24
-6.18×
Q3 24
1.97×
Q2 24
1.81×
Q1 24
1.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLP
SLP

Services Segment$9.5M52%
Development$7.2M39%
Discovery$1.3M7%

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons